• Mon, November 7, 2016

by: WOPRAI

Market Maker Surveillance Report. COGT, CNAB, AERO, CANN, CNBX, AXIM, Winning Stocks With Lowest Price Friction For Monday, No

by: WOPRAI

Market Maker Surveillance Report. MDCA, IAU, GDX, GDXJ, CXRX, YUMC, Highest Net Sell Volume and Negative Price Friction For Mo

by: WOPRAI

Market Maker Surveillance Report. TLT, PBF, GLD, OPK, BWX, VXX, Bearishly Biased Price Friction For Monday, November 7th 2016

by: WOPRAI

Globus Medical Inc. (NYSE:GMED), Up By $1.09 (5.08%) After BUYINS.NET SqueezeTrigger Report Released on Friday, November 4th 20

by: WOPRAI

Great Basin Scientific Inc. (PINK:GBSN), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined

by: WOPRAI

AVEO Pharmaceuticals Inc. (NASDAQ:AVEO), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined

by: WOPRAI

DYN SqueezeTrigger Price is $8.53. There is $147,560,831 That Short Sellers Still Need To Cover.

by: WOPRAI

Essex Rental Corp (OTC:ESSX), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Repo

by: WOPRAI

Tvia Inc (Old) (NASDAQ:TVIA), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Repo

by: WOPRAI

NACCO Industries Inc. (NYSE:NC), Up By $8.64 (12.05%) After BUYINS.NET SqueezeTrigger Report Released on Monday, October 24th 2

by: WOPRAI

Median Group Inc. (OTC:CHMD), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Report

by: WOPRAI

EBS SqueezeTrigger Price is $25.58. There is $112,699,721 That Short Sellers Still Need To Cover.

by: WOPRAI

WEYS SqueezeTrigger Price is $25.54. There is $6,058,508 That Short Sellers Still Need To Cover.

by: WOPRAI

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Out

by: WOPRAI

TechTarget Inc. (NASDAQ:TTGT), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Report

by: WOPRAI

Sage Therapeutics (NASDAQ:SAGE), Up By $3.56 (9.05%) After BUYINS.NET SqueezeTrigger Report Released on Friday, November 4th 20

by: WOPRAI

Aimmune Therapeutics Inc. (NASDAQ:AIMT), Up By $1.22 (7.04%) After BUYINS.NET SqueezeTrigger Report Released on Friday, Novembe

by: WOPRAI

iShares FTSE NAREIT Mortgage REITs Index Fund (NYSE:REM), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditi

by: WOPRAI

iShares MSCI Japan Index Fund (NYSE:EWJ), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In

by: WOPRAI

Ducommun Inc. (NYSE:DCO), Up By $2.36 (11.63%) After BUYINS.NET SqueezeTrigger Report Released on Friday, November 4th 2016 at

by: WOPRAI

Alexco Resource Corporation (NYSE:AXU), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined I

by: WOPRAI

Seaspan Corporation (NYSE:SSW), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Re

by: WOPRAI

Heritage Commerce Corp (NASDAQ:HTBK) Down By 6.13% ($0.67) From $10.900 After BUYINS.NET Report Predicted Strength After Earnin

by: WOPRAI

PRIM SqueezeTrigger Price is $19.07. There is $49,554,054 That Short Sellers Still Need To Cover.

by: WOPRAI

SMCI SqueezeTrigger Price is $22.07. There is $59,420,725 That Short Sellers Still Need To Cover.

by: WOPRAI

PGTI SqueezeTrigger Price is $9.81. There is $26,691,795 That Short Sellers Still Need To Cover.

by: WOPRAI

VDTH SqueezeTrigger Price is $8.91. There is $1,392,412 That Short Sellers Still Need To Cover.

by: WOPRAI

SGNL SqueezeTrigger Price is $2.14. There is $69,550 That Short Sellers Still Need To Cover.

by: WOPRAI

BID SqueezeTrigger Price is $35.68. There is $353,354,958 That Short Sellers Still Need To Cover.

by: WOPRAI

PWOD SqueezeTrigger Price is $41.23. There is $6,795,187 That Short Sellers Still Need To Cover.

by: WOPRAI

XOMA, ORRF, NEM, JBLU, WINA, NTRS, Expected to Trade Lower After Bearish Insider Trading

by: WOPRAI

KSS Expected To Be Down Before Next Earnings Releases

by: WOPRAI

FTEK, IPAR, GBL, INWK, CLDX Expected To Be Down After Next Earnings Releases

by: WOPRAI

HOV Expected To Be Up Before Next Earnings Releases

by: WOPRAI

MIDD, NP, SWX, VSAT, CPA, CXO Expected To Be Up After Next Earnings Releases

by: WOPRAI

Paul Newsome Upgraded (AON) to Strong Buy on, Nov 7th, 2016

by: WOPRAI

Haendel St. Juste Upgraded (AAT) to Strong Buy on, Nov 7th, 2016

by: WOPRAI

Alexander Hacking Initiated (AA) at Strong Buy on, Nov 7th, 2016

by: WOPRAI

Carlos De Alba Initiated (AA) at Buy on, Nov 7th, 2016

by: WOPRAI

Christopher Raymond Upgraded (BIIB) to Buy on, Nov 7th, 2016

by: WOPRAI

Geoffrey Porges Upgraded (BIIB) to Buy on, Nov 7th, 2016

by: WOPRAI

Sheryl Skolnick Upgraded (AMED) to Strong Buy on, Nov 7th, 2016

by: WOPRAI

Christopher Raymond Downgraded (BMRN) to Hold on, Nov 7th, 2016

by: WOPRAI

Maurice Choy Upgraded (TAC) to Hold on, Nov 7th, 2016

by: WOPRAI

Jonathan Hughes Upgraded (DOC) to Strong Buy on, Nov 7th, 2016

by: WOPRAI

Jon Windham Upgraded (WM) to Buy on, Nov 7th, 2016

by: WOPRAI

David Raso Upgraded (TKR) to Strong Buy on, Nov 7th, 2016

by: WOPRAI

Sumant Kulkarni Downgraded (TEVA) to Hold on, Nov 7th, 2016

Christopher Raymond Upgraded (BIIB) to Buy on, Nov 7th, 2016

Christopher Raymond of Piper Sandler, Upgraded "Biogen Inc." (BIIB) to Buy on, Nov 7th, 2016.

Christopher has made no other calls on BIIB in the last 4 months.



There are 2 other peers that have a rating on BIIB. Out of the 2 peers that are also analyzing BIIB, 1 agrees with Christopher's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Eun Yang of "Jefferies" Maintained at Hold with Decreased Target to $316 on, Wednesday, October 5th, 2016


This is the rating of the analyst that currently disagrees with Christopher

  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $368 on, Wednesday, August 17th, 2016

Like: 👍